Kinnate Biopharma Inc. (KNTE)

The total Gamma Exposure (GEX) for KNTE across all expirations is 0 shares per 1% move, with 0 from calls and 0 from puts. The put-call GEX ratio of n/a reflects balanced positioning between puts and calls. The highest gamma concentration is at the Jan 16, 26 expiration with 0 net GEX, which may act as a pivot point for price action. Near-term exposure for Jan 16, 26 suggests possible volatility from negative gamma effects.